To do so, we established an indirect ELISA (enzyme-linked immunosorbent assay) that measures the actual ARID1A protein concentrations in tumor lysates with extraordinarily high precision and accuracy (compare Supplementary Table S1). This evidence concerns the gene ARID1A and neoplasm.